SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Maurice Pérol

Maurice Pérol

Centre Léon Bérard, Lyon

Dr. Maurice Pérol is Head of Thoracic Oncology in the Medical Oncology Department at the Centre Léon Bérard in Lyon, France. His research focuses on clinical phase I, II and III trials in lung cancer, particularly advanced non-small cell lung cancer, including targeted therapies, immunotherapy and antibody-drug conjugates. A principal or key investigator in numerous French and international cooperative studies, he has authored over 140 peer-reviewed publications, chaired the Groupe Français de Pneumo-Cancérologie (GFPC), served on the IFCT Scientific Board, and sits on the touchONCOLOGY editorial board. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Maurice Pérol

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates